REFERENCES

1. Wang J, Qiu Y, Yang Y, et al. Impact of cirrhosis on long-term survival outcomes of patients with intrahepatic cholangiocarcinoma. Cancer Med 2022;11:3633-42.

2. Burton A, Tataru D, Driver RJ, et al. HCC-UK/BASL/NCRAS Partnership Steering Group. Primary liver cancer in the UK: incidence, incidence-based mortality, and survival by subtype, sex, and nation. JHEP Rep 2021;3:100232.

3. Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G. Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol 2020;72:364-77.

4. Spolverato G, Kim Y, Ejaz A, et al. Conditional probability of long-term survival after liver resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis of 535 patients. JAMA Surg 2015;150:538-45.

5. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? a meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 2012;57:69-76.

6. Thakral N, Gonzalez T, Nano O, Shin SH, Samuels S, Hussein A. Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival. BMC Gastroenterol 2023;23:151.

7. Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 2008;15:2787-94.

8. de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011;29:3140-5.

9. Doussot A, Gonen M, Wiggers JK, et al. Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models. J Am Coll Surg 2016;223:493-505.e2.

10. Molina V, Ferrer-Fábrega J, Sampson-Dávila J, et al. Intention-to-treat curative liver resection in patients with "very early" intrahepatic cholangiocarcinoma. Langenbecks Arch Surg 2020;405:967-75.

11. van Keulen AM, Büttner S, Erdmann JI, et al. Major complications and mortality after resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. Surgery 2023;173:973-82.

12. Langella S, Russolillo N, Ossola P, et al. Recurrence after curative resection for intrahepatic cholangiocarcinoma: how to predict the chance of repeat hepatectomy? J Clin Med 2021;10:2820.

13. Tsilimigras DI, Mehta R, Moris D, et al. A machine-based approach to preoperatively identify patients with the most and least benefit associated with resection for intrahepatic cholangiocarcinoma: an international multi-institutional analysis of 1146 patients. Ann Surg Oncol 2020;27:1110-9.

14. O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. results in 93 consecutive patients. Ann Surg 1988;207:373-9.

15. Pichlmayr R, Weimann A, Tusch G, Schlitt HJ. Indications and role of liver transplantation for malignant tumors. Oncologist 1997;2:164-70.

16. Sapisochin G, C Rodríguez de Lope, Gastaca M, et al. "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients? Am J Transplant 2014;14:660-7.

17. Sapisochin G, de Lope CR, Gastaca M, et al. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study. Ann Surg 2014;259:944-52.

18. Sapisochin G, Facciuto M, Rubbia-Brandt L, et al. iCCA International Consortium. Liver transplantation for "very early" intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment. Hepatology 2016;64:1178-88.

19. De Martin E, Rayar M, Golse N, et al. Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in the setting of cirrhosis. Liver Transpl 2020;26:785-98.

20. Lunsford KE, Javle M, Heyne K, et al. Methodist-MD Anderson Joint Cholangiocarcinoma Collaborative Committee (MMAJCCC). Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series. Lancet Gastroenterol Hepatol 2018;3:337-48.

21. McMillan RR, Javle M, Kodali S, et al. Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma. Am J Transplant 2022;22:823-32.

22. Takahashi K, Obeid J, Burmeister CS, et al. Intrahepatic cholangiocarcinoma in the liver explant after liver transplantation: histological differentiation and prognosis. Ann Transplant 2016;21:208-15.

23. Ziogas IA, Giannis D, Economopoulos KP, et al. Liver transplantation for intrahepatic cholangiocarcinoma: a meta-analysis and meta-regression of survival rates. Transplantation 2021;105:2263-71.

24. Jung DH, Hwang S, Song GW, et al. Clinicopathological features and prognosis of intrahepatic cholangiocarcinoma after liver transplantation and resection. Ann Transplant 2017;22:42-52.

25. Safdar NZ, Hakeem AR, Faulkes R, et al. Outcomes after liver transplantation with incidental cholangiocarcinoma. Transpl Int 2022;35:10802.

26. Rayar M, Levi Sandri GB, Houssel-Debry P, Camus C, Sulpice L, Boudjema K. Multimodal Therapy including Yttrium-90 radioembolization as a bridging therapy to liver transplantation for a huge and locally advanced intrahepatic cholangiocarcinoma. J Gastrointestin Liver Dis 2016;25:401-4.

27. Sapisochin G, Javle M, Lerut J, et al. Liver transplantation for cholangiocarcinoma and mixed hepatocellular cholangiocarcinoma: working group report from the ILTS transplant oncology consensus conference. Transplantation 2020;104:1125-30.

28. Akamatsu N, Sakamoto Y, Hasegawa K. Liver transplantation for the solitary intrahepatic cholangiocarcinoma less than 2 cm in diameter. Hepatobiliary Surg Nutr 2017;6:332-4.

29. Menon K, Vijayashanker A, Murphy J, et al. NHS Blood and Transplant Liver Transplantation for Colorectal Liver Metastases Fixed Term Working Group. Liver transplantation for isolated unresectable colorectal liver metastases - protocol for a service evaluation in the United Kingdom - UKCoMET study. HPB 2023;25:684-92.

30. NHS blood and transplant. (POL195/14) - liver transplantation: selection criteria and recipient registration. Available from: https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/27372/pol195-120822.pdf [Last accessed on 2 Aug 2023].

31. Liu Y, Wang B, Mo X, Tang K, He J, Hao J. A deep learning workflow for mass-forming intrahepatic cholangiocarcinoma and hepatocellular carcinoma classification based on MRI. Curr Oncol 2022;30:529-44.

32. Ni T, Shang XS, Wang WT, Hu XX, Zeng MS, Rao SX. Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size. Br J Radiol 2018;91:20180017.

33. Jeon Y, Kwon SM, Rhee H, et al. Molecular and radiopathologic spectrum between HCC and intrahepatic cholangiocarcinoma. Hepatology 2023;77:92-108.

34. Beetz O, Timrott A, Weigle CA, et al. Proposal of a new definition of "very early" intrahepatic cholangiocarcinoma-a retrospective single-center analysis. J Clin Med 2021;10:4073.

35. Pillai A. Mixed hepatocellular-cholangiocarcinoma: is it time to rethink consideration for liver transplantation? Liver Transpl 2018;24:1329-30.

36. Ma KW, Chok KSH, She WH, et al. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? a propensity score-matched analysis. Hepatol Int 2018;12:167-73.

37. Cannella R, Cunha GM, Catania R, et al. Magnetic resonance imaging of nonhepatocellular malignancies in chronic liver disease. Magn Reson Imaging Clin N Am 2021;29:404-18.

38. Lee DD, Croome KP, Musto KR, et al. Liver transplantation for intrahepatic cholangiocarcinoma. Liver Transpl 2018;24:634-44.

39. Sapisochin G, Ivanics T, Heimbach J. Liver transplantation for intrahepatic cholangiocarcinoma: ready for prime time? Hepatology 2022;75:455-72.

40. Moro A, Mehta R, Sahara K, et al. The impact of preoperative CA19-9 and CEA on outcomes of patients with intrahepatic cholangiocarcinoma. Ann Surg Oncol 2020;27:2888-901.

41. Wu H, Liang Y, Wang Z, et al. Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma. Acta Radiol 2023;64:926-35.

42. Min JH, Lee MW, Park HS, et al. LI-RADS version 2018 targetoid appearances on gadoxetic acid-enhanced MRI: interobserver agreement and diagnostic performance for the differentiation of HCC and Non-HCC malignancy. AJR Am J Roentgenol 2022;219:421-32.

43. Park S, Lee Y, Kim H, et al. Subtype classification of intrahepatic cholangiocarcinoma using liver MR imaging features and its prognostic value. Liver Cancer 2022;11:233-46.

44. Ma KW, Cheung TT, Leung B, et al. Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: a meta-analysis. Medicine 2019;98:e14013.

45. Bridgewater J, Fletcher P, Palmer DH, et al. BILCAP study group. Long-term outcomes and exploratory analyses of the randomized phase III BILCAP study. J Clin Oncol 2022;40:2048-57.

46. Panayotova GG, Guarrera JV, Lunsford KE. Should we reevaluate liver transplantation as an alternative to resection for the treatment of intrahepatic cholangiocarcinoma? Liver Transpl 2020;26:748-50.

47. Gül-Klein S, Schmitz P, Schöning W, et al. The role of immunosuppression for recurrent cholangiocellular carcinoma after liver transplantation. Cancers 2022;14:2890.

48. Patkowski W, Stankiewicz R, Grąt M, Krasnodębski M, Kornasiewicz O, Krawczyk M. Poor outcomes after liver transplantation in patients with incidental cholangiocarcinoma irrespective of tumor localization. Transplant Proc 2014;46:2774-6.

49. NCT02878473- Liver transplantation for early intrahepatic cholangiocarcinoma (LT for iCCA). Available from: https://clinicaltrials.gov/ct2/show/NCT02878473 [Last accessed on 2 Aug 2023].

50. NCT04195503- Liver transplant for stable advanced intrahepatic cholangiocarcinoma. Available from: https://clinicaltrials.gov/ct2/show/NCT04195503 [Last accessed on 2 Aug 2023].

51. NCT04556214- Liver transplantation for non-resectable intrahepatic cholangiocarcinoma: a prospective exploratory trial (TESLA Trial). Available from: https://clinicaltrials.gov/ct2/show/NCT04556214 [Last accessed on 2 Aug 2023].